In 2023, the market for negative pressure wound therapy is projected to be worth USD 6.5 billion. By 2033, the market is anticipated to have grown at a compound annual growth rate (CAGR) of 5.3% to reach USD 10.8 billion.
The rise in chronic wounds such as diabetic foot ulcers, post-surgical ulcers, and pressure ulcers has been identified as a key driver behind the increasing adoption of NPWT devices. Coupled with the growing expenditure on wound care, this trend is expected to sustain the market’s upward trajectory over the next decade.
Furthermore, the shift towards utilizing NPWT devices in homecare settings is poised to accelerate market growth. These devices not only help mitigate the risk of infections but also contribute to reducing overall healthcare costs, making them increasingly attractive for patients and healthcare providers alike.
“The demand for negative pressure wound therapy solutions is robust and set to expand significantly in the coming years,” stated FMI. “This growth is driven by the urgent need to effectively manage chronic wounds and enhance patient outcomes, especially in the context of rising healthcare costs globally.”
Negative Pressure Wound Therapy Market Trend Analysis
- Rising prevalence of chronic wounds such as diabetic foot ulcers, post-surgical ulcers, and pressure ulcers, and increasing wound care spending, drive the demand for negative pressure wound therapy.
- The growing adoption of negative pressure wound therapy devices in homecare settings to minimize the risk of infections and reduce healthcare costs will further push the demand for negative pressure wound therapy during the forthcoming years.
Negative Pressure Wound Therapy Market Drivers
- The rising prevalence of chronic wounds, such as diabetic ulcers, pressure ulcers, and venous leg ulcers, is a significant driver for the negative pressure wound therapy market.
- The growing global aging population is expanding, increasing chronic diseases and age-related health issues. Elderly individuals are more susceptible to chronic wounds, driving the demand for an effective treatment option.
- The rapid growth of wound care clinics and specialized wound care centers has driven the demand for the negative pressure wound therapy market.
- The growing preference for cost-effective wound treatment using NPWT devices, such as portable NPWT devices and single-use NPWT devices in developing nations, drives the market demand.
- The growing demand for negative pressure wound therapy for specialized patient populations, including neonates, burn patients, and individuals with complex surgical wounds, traumatic injuries, or ostomies.
- Advancement in negative pressure wound therapy technology is expected to impact the negative pressure wound therapy market positively.
Key Takeaways:
- From 2018 to 2022, the negative pressure wound therapy market demand expanded at a CAGR of 3.5%
- Based on product type, the standalone NPWT devices segment is expected to rise at a CAGR of 3.5%.
- Global negative pressure wound therapy demand in the United Kingdom is predicted to account for a CAGR of 5.1% from 2023 to 2033.
- In the United States, the market is expected to account for a CAGR of 5.2% between 2023 and 2033.
- China is projected to expand by a value CAGR of 4.9% between 2023 and 2033.
- By 2033, India’s negative pressure wound therapy market is anticipated to record a CAGR of 4.8% during the forecast period.
Competitive Landscape
Leading negative pressure wound therapy device manufacturers are increasingly focusing on expanding their product offerings to strengthen their customer base. Moreover, they are adopting growth strategies such as new product launches, partnerships, acquisitions, mergers, collaborations, etc. to expand their global footprint and gain a competitive edge in the global negative pressure wound therapy market. For instance,
- In March 2020, Smith+Nephew, the global medical technology business, announced the USA launch of the PICO 14 single-use negative pressure wound therapy system for use on high-risk surgical patients.
- In April 2021, Joerns Healthcare, a leading wound solutions provider, announced a nationwide partnership with Medela to expand access to innovative negative pressure wound therapy. Under this agreement, Joerns will expand its wound care portfolio to include the full Medela line of negative pressure wound therapy products, including the Invia Liberty and Invia Motion 60 NPWT Systems.
Key Companies Profiled
- Cardinal Health
- Mölnlycke Health Care
- Acelity L.P. Inc. (3M)
- Lohmann & Rauscher GmbH & Co. KG
- Smith & Nephew
- ConvaTec Inc.
- DeRoyal Industries, Inc.
- HARTMANN, Medela LLC
- Haromed Bvba (Belgium)
- Carilex Medical GmbH.
- Genadyne Biotechnologies, Inc.
- Cork Medical, LLC
- Alleva Medical Ltd. (Devon Medical Products
- Argentum Medical, LLC
Full Report Revealed
Negative Pressure Wound Therapy Market by Category
By Product Type:
- Standalone NPWT Devices
- Direct Sales
- Rental Sales
- Product
- Services
- Portable NPWT Devices
- Direct Sales
- Rental Sales
- Product
- Services
- Single-Use NPWT Devices
- Direct Sales
- Rental Sales
- Product
- Services
- NPWT Dressings
- Foam Dressings
- Hydrocolloid Dressings
- Standard Gauze Dressings
- NPWT Accessories
By Indication:
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Post-Surgical Ulcers & Open Wound
- Burn Wounds
- Other Wounds
By End-User:
- Hospitals
- Acute Care Centers
- Community Hospitals
- Ambulatory Surgical Centers
- Trauma Care Centers
- Specialty Clinics
- Home Care Settings
- Long-Term Care Centers
- Skilled Nursing Facilities
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- Middle East and Africa
- Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
